Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $12.6 in the prior trading day, Astria Therapeutics Inc (NASDAQ: ATXS) closed at $12.65, up 0.40%. In other words, the price has increased by $0.40 from its previous closing price. On the day, 0.53 million shares were traded. ATXS stock price reached its highest trading level at $12.68 during the session, while it also had its lowest trading level at $12.605.
Ratios:
Our goal is to gain a better understanding of ATXS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.78 and its Current Ratio is at 10.78. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
On September 17, 2025, H.C. Wainwright reiterated its Buy rating and also lowered its target price recommendation from $16 to $20. On April 29, 2025, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $47.Cantor Fitzgerald initiated its Overweight rating on April 29, 2025, with a $47 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATXS now has a Market Capitalization of 722123200 and an Enterprise Value of 594185216. For the stock, the TTM Price-to-Sale (P/S) ratio is 1017.07 while its Price-to-Book (P/B) ratio in mrq is 5.18. Its current Enterprise Value per Revenue stands at 841.622.
Stock Price History:
The Beta on a monthly basis for ATXS is 0.08, which has changed by 0.21986496 over the last 52 weeks, in comparison to a change of 0.1326145 over the same period for the S&P500. Over the past 52 weeks, ATXS has reached a high of $12.72, while it has fallen to a 52-week low of $3.56. The 50-Day Moving Average of the stock is 17.37%, while the 200-Day Moving Average is calculated to be 78.24%.
Shares Statistics:
The stock has traded on average 1.75M shares per day over the past 3-months and 1024720 shares per day over the last 10 days, according to various share statistics. A total of 56.43M shares are outstanding, with a floating share count of 49.96M. Insiders hold about 12.49% of the company’s shares, while institutions hold 76.69% stake in the company. Shares short for ATXS as of 1763078400 were 5086350 with a Short Ratio of 2.91, compared to 1760486400 on 4024158. Therefore, it implies a Short% of Shares Outstanding of 5086350 and a Short% of Float of 11.1899994.
Earnings Estimates
Astria Therapeutics Inc (ATXS) is presently subject to a detailed evaluation by 3 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.6, with high estimates of -$0.54 and low estimates of -$0.65.
Analysts are recommending an EPS of between -$2.0 and -$2.26 for the fiscal current year, implying an average EPS of -$2.12. EPS for the following year is -$2.36, with 4.0 analysts recommending between -$2.01 and -$2.75.